Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Costimulation provided by DNA immunization enhances antitumor immunity

M Corr1, H Tighe, D Lee

  • 1Department of Medicine, The Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, La Jolla 92093-0663, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|November 20, 1997
PubMed
Summary

Secondary costimulatory signals are crucial for activating cytotoxic T lymphocytes (CTL). B7-1 gene vaccination effectively induces CTL responses and enhances tumor immunity, unlike B7-2.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Histopathologic Features of Right and Left Sided Colon Cancer.

ANZ journal of surgery·2026
Same author

2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.

Leukemia & lymphoma·2016
Same author

Immunoglobulin Gene Rearrangement and Expression in B-CLL.

Leukemia & lymphoma·2016
Same author

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia.

Leukemia & lymphoma·2016
Same author

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.

Blood cancer journal·2015
Same author

Lymphocyte dysfunction caused by deficiencies in purine metabolism.

Immunology today·2014

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • T cell receptor (TCR) interaction with MHC class I-bound antigens alone is insufficient for cytotoxic T lymphocyte (CTL) priming.
  • Secondary costimulatory signals are essential for initiating a robust CTL response.

Purpose of the Study:

  • To determine the minimal requirements for activating an antigen-specific CTL response in vivo.
  • To compare the efficacy of different costimulatory ligands in gene vaccination strategies.

Main Methods:

  • Mice were injected with plasmid DNA encoding a MHC class I-restricted peptide antigen (minigene) and various membrane-bound costimulatory ligands.
  • Intradermal and intramuscular injection routes were utilized.
  • CTL responses, antibody (Ab) responses, and tumor survival rates were assessed.

Related Experiment Videos

Main Results:

  • Antigen-specific CTL responses were primed only when the antigen was co-delivered with an ectopically expressed costimulatory ligand.
  • Plasmid encoding B7-1 was significantly more potent in stimulating cytolytic responses compared to B7-2.
  • B7-2 preferentially enhanced antigen-specific Ab responses, while B7-1 and B7-2 co-administration with OVA prolonged survival in tumor-challenged mice.

Conclusions:

  • Functional B7-1 transfection can be achieved in vivo, leading to the selective induction of CTL.
  • B7-1 plasmids should be co-administered with naked DNA vaccines targeting tumor-specific cellular immunity.
  • This study highlights the differential roles of B7-1 and B7-2 in shaping adaptive immune responses.